BCG-Unresponsive NMIBC: Insights for Newer Treatment Modalities
Dec 31, 2024 · Katie S. Murray, DO, offers advice to urologists considering the adoption of newer treatment modalities for BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC), …
2024 Urology Times pipeline report
Jan 1, 2025 · The FDA granted full approval to erdafitinib (Balversa) for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 …
Upper tract urothelial carcinoma: An in-depth review for urologists
Oct 11, 2024 · Persily is a urology resident at New York University Langone Health in New York, New York.Thakker is a urology resident at New York University Langone Health.Murray is a …
FDA grants clearance to NanoKnife System for prostate tissue …
Dec 9, 2024 · Key Takeaways. The NanoKnife System received FDA 510(k) clearance for prostate tissue ablation, utilizing irreversible electroporation technology to target tumors while …
Painless testicular swelling: What’s your diagnosis? - Urology Times
Nov 5, 2015 · Figure 2. Transverse view of the right testicle showing loculated hydrocele. Diagnosis: Testicular hydrocele Discussion. Although hydroceles are typically idiopathic in …
Shock wave therapy: ED cure or unproven treatment? - Urology …
Aug 6, 2019 · Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there …
Dr. Reiter discusses accuracy of PSMA-PET scans - Urology Times
Mar 5, 2024 · Prostate-specific membrane antigen (PSMA)-PET imaging has proven to be disruptive technology in the detection of prostate cancer. In this interview, Robert Reiter, MD, …
BPH is linked with erectile dysfunction in US men
Oct 19, 2024 · Discussing the background for the study, investigator Olivia Paulsen told Urology Times, “We know that [BPH] has an association with lower urinary tract symptoms, but its …
Optilume shows strong freedom from reintervention rates in …
May 3, 2024 · Findings from the ROBUST III study (NCT03499964) were presented at the 2024 American Urological Association Annual Meeting by Sean Elliott, MD, MS, professor, vice …
Vibegron and mirabegron efficacy similar in OAB, but patients …
Apr 30, 2023 · Vibegron (Gemtesa) and mirabegron (Myrbetriq) demonstrated similar efficacy and safety in a comparative study of the 2 treatments in female patients with overactive bladder …